SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?


To: mesaone who wrote (1098)9/14/1998 8:38:00 AM
From: mesaone  Read Replies (1) | Respond to of 1432
 
on may 12, the short reporting period closed for the first time after
btim made national mkt. i suspect assensio was so panicked then
(calling it obb) because as a nat mkt, all short sales must be
reported. this is, i think, why btim went there. Assensio lost his ability to drive the stock down on massive naked shorting, and had to count on his wannabes to bail him out. i think the shorts have seen that it doesn't take a lot of real buying to move the price up, and they are afraid of another squeeze.

It will be interesting to see this months short numbers. I know that I have moved most of my stock into my cash account to keep it out of the hands of the shorts. Even the most vocal of the shorts all agree that Hextend will get FDA approval, and as we move closer to approval, the price that the shorts have to pay to get their hands on available stock will certainly be dear.

inch.com